BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ribeiro AJS, Yang X, Patel V, Madabushi R, Strauss DG. Liver Microphysiological Systems for Predicting and Evaluating Drug Effects. Clin Pharmacol Ther 2019;106:139-47. [PMID: 30993668 DOI: 10.1002/cpt.1458] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Moradi E, Jalili-Firoozinezhad S, Solati-Hashjin M. Microfluidic organ-on-a-chip models of human liver tissue. Acta Biomater 2020;116:67-83. [PMID: 32890749 DOI: 10.1016/j.actbio.2020.08.041] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 11.0] [Reference Citation Analysis]
2 Anklam E, Bahl MI, Ball R, Beger RD, Cohen J, Fitzpatrick S, Girard P, Halamoda-Kenzaoui B, Hinton D, Hirose A, Hoeveler A, Honma M, Hugas M, Ishida S, Kass GE, Kojima H, Krefting I, Liachenko S, Liu Y, Masters S, Marx U, McCarthy T, Mercer T, Patri A, Pelaez C, Pirmohamed M, Platz S, Ribeiro AJ, Rodricks JV, Rusyn I, Salek RM, Schoonjans R, Silva P, Svendsen CN, Sumner S, Sung K, Tagle D, Tong L, Tong W, Eijnden-van-Raaij JVD, Vary N, Wang T, Waterton J, Wang M, Wen H, Wishart D, Yuan Y, Slikker W Jr. Emerging technologies and their impact on regulatory science. Exp Biol Med (Maywood) 2021;:15353702211052280. [PMID: 34783606 DOI: 10.1177/15353702211052280] [Reference Citation Analysis]
3 Li Z, Xiang S, Li EN, Fritch MR, Alexander PG, Lin H, Tuan RS. Tissue Engineering for Musculoskeletal Regeneration and Disease Modeling. Handb Exp Pharmacol 2021;265:235-68. [PMID: 33471201 DOI: 10.1007/164_2020_377] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Dame K, Ribeiro AJ. Microengineered systems with iPSC-derived cardiac and hepatic cells to evaluate drug adverse effects. Exp Biol Med (Maywood) 2021;246:317-31. [PMID: 32938227 DOI: 10.1177/1535370220959598] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sakolish C, Reese CE, Luo YS, Valdiviezo A, Schurdak ME, Gough A, Taylor DL, Chiu WA, Vernetti LA, Rusyn I. Analysis of reproducibility and robustness of a human microfluidic four-cell liver acinus microphysiology system (LAMPS). Toxicology 2021;448:152651. [PMID: 33307106 DOI: 10.1016/j.tox.2020.152651] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Rubiano A, Indapurkar A, Yokosawa R, Miedzik A, Rosenzweig B, Arefin A, Moulin CM, Dame K, Hartman N, Volpe DA, Matta MK, Hughes DJ, Strauss DG, Kostrzewski T, Ribeiro AJS. Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation. Clin Transl Sci 2021;14:1049-61. [PMID: 33382907 DOI: 10.1111/cts.12969] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
7 Hargrove-Grimes P, Low LA, Tagle DA. Microphysiological systems: What it takes for community adoption. Exp Biol Med (Maywood) 2021;246:1435-46. [PMID: 33899539 DOI: 10.1177/15353702211008872] [Reference Citation Analysis]
8 Ferrari E, Palma C, Vesentini S, Occhetta P, Rasponi M. Integrating Biosensors in Organs-on-Chip Devices: A Perspective on Current Strategies to Monitor Microphysiological Systems. Biosensors (Basel) 2020;10:E110. [PMID: 32872228 DOI: 10.3390/bios10090110] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
9 Alluri RV, Li R, Varma MVS. Transporter–enzyme interplay and the hepatic drug clearance: what have we learned so far? Expert Opinion on Drug Metabolism & Toxicology 2020;16:387-401. [DOI: 10.1080/17425255.2020.1749595] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
10 Kulsharova G, Kurmangaliyeva A. Liver microphysiological platforms for drug metabolism applications. Cell Prolif 2021;:e13099. [PMID: 34291515 DOI: 10.1111/cpr.13099] [Reference Citation Analysis]
11 Bouwmeester MC, Bernal PN, Oosterhoff LA, van Wolferen ME, Lehmann V, Vermaas M, Buchholz MB, Peiffer QC, Malda J, van der Laan LJW, Kramer NI, Schneeberger K, Levato R, Spee B. Bioprinting of Human Liver-Derived Epithelial Organoids for Toxicity Studies. Macromol Biosci 2021;:e2100327. [PMID: 34559943 DOI: 10.1002/mabi.202100327] [Reference Citation Analysis]
12 Mattes WB. In vitro to in vivo translation. Current Opinion in Toxicology 2020;23-24:114-8. [DOI: 10.1016/j.cotox.2020.09.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Zietek T, Boomgaarden WAD, Rath E. Drug Screening, Oral Bioavailability and Regulatory Aspects: A Need for Human Organoids. Pharmaceutics 2021;13:1280. [PMID: 34452240 DOI: 10.3390/pharmaceutics13081280] [Reference Citation Analysis]
14 Dai Y, Yang Y, Liu B, Qiao L. Water-in-oil microcompartments for the study of biomimetic drug metabolism. J Colloid Interface Sci 2020;569:378-85. [PMID: 32126350 DOI: 10.1016/j.jcis.2020.02.096] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Vollertsen AR, Vivas A, van Meer B, van den Berg A, Odijk M, van der Meer AD. Facilitating implementation of organs-on-chips by open platform technology. Biomicrofluidics 2021;15:051301. [PMID: 34659603 DOI: 10.1063/5.0063428] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Mannaerts I, Eysackers N, Anne van Os E, Verhulst S, Roosens T, Smout A, Hierlemann A, Frey O, Leite SB, van Grunsven LA. The fibrotic response of primary liver spheroids recapitulates in vivo hepatic stellate cell activation. Biomaterials 2020;261:120335. [PMID: 32891040 DOI: 10.1016/j.biomaterials.2020.120335] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
17 Wang H, Brown PC, Chow ECY, Ewart L, Ferguson SS, Fitzpatrick S, Freedman BS, Guo GL, Hedrich W, Heyward S, Hickman J, Isoherranen N, Li AP, Liu Q, Mumenthaler SM, Polli J, Proctor WR, Ribeiro A, Wang JY, Wange RL, Huang SM. 3D cell culture models: Drug pharmacokinetics, safety assessment, and regulatory consideration. Clin Transl Sci 2021. [PMID: 33982436 DOI: 10.1111/cts.13066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Rusyn I, Roth A. Editorial overview of the special issue on application of tissue chips in toxicology. Toxicology 2021;450:152687. [PMID: 33484733 DOI: 10.1016/j.tox.2021.152687] [Reference Citation Analysis]
19 Sakolish C, Luo YS, Valdiviezo A, Vernetti LA, Rusyn I, Chiu WA. Prediction of hepatic drug clearance with a human microfluidic four-cell liver acinus microphysiology system. Toxicology 2021;463:152954. [PMID: 34543702 DOI: 10.1016/j.tox.2021.152954] [Reference Citation Analysis]